DRW Securities, LLC
Broker-DealerPosition in XERS — Xeris Biopharma Holdings, Inc.
CIK 1481986
CHICAGO, IL
Position in XERS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$213,480
New position
Shares Held
36,807
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DRW Securities, LLC holds $2,827,228 across 9 Drug Manufacturers - Specialty & Generic names. XERS ranks #6 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
25,671 | $773,210 | |
| 2 | ALKS |
Alkermes plc.
|
20,180 | $713,564 | |
| 3 | VTRS |
Viatris Inc
|
26,173 | $353,597 | |
| 4 | PRGO |
PERRIGO Co plc
|
28,706 | $308,302 | |
| 5 | ZTS |
Zoetis Inc.
|
1,824 | $215,615 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
36,807 | $213,480 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
21,845 | $207,964 | |
| 8 | SNOA |
Sonoma Pharmaceuticals, Inc.
|
12,015 | $25,591 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,480 | 36,807 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||